Ceruloplasmin and myeloperoxidase in complex affect the enzymatic properties of each other

Free Radical Research

Volumn 42, Issue 11-12, 2008, Pages 989-998

  Sokolov, Alexej ^a   Ageeva, Kira ^a   Pulina, Maria ^a   Cherkalina, Olga ^a   Samygina, Valeria ^b   Vlasova, Irina I ^c   Panasenko, Oleg ^c   Zakharova, Elena ^a   Vasilyev, Vadim ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Russian Federation)

^b SHUBNIKOV INSTITUTE OF CRYSTALLOGRAPHY   (Russian Federation)

^c FEDERAL RESEARCH AND CLINICAL CENTER OF PHYSICAL CHEMICAL MEDICINE OF FEDERAL MEDICAL BIOLOGICAL AGENCY   (Russian Federation)

Author keywords

Activating enzyme; Ceruloplasmin; Inhibitory enzyme; Limited proteolysis; Myeloperoxidase; Protein protein interaction

Indexed keywords

CERULOPLASMIN; MYELOPEROXIDASE; PHENYLENEDIAMINE;

ANTIOXIDANT ACTIVITY; ARTICLE; BINDING SITE; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME METABOLISM; HUMAN; HUMAN CELL; LEUKOCYTE; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

CATALYSIS; CERULOPLASMIN; CHLORINE; ENZYME ACTIVATION; HUMANS; HYDROLYSIS; LEUKOCYTES; OXIDOREDUCTASES; PEROXIDASE; SERINE ENDOPEPTIDASES; SPECTROPHOTOMETRY;

EID: 57649201397     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760802566574     Document Type: Article

References (47)

1. Osaki, S., Johnson, DA and Frieden, E. (1966) The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J Biol Chem, 241, pp. 2746-2751.
2. Stoj, C. and Kosman, DJ. (2003) Cuprous oxidase activity of yeast Fet3p and human ceruloplasmin: Implication for function. FEBS Lett, 554, pp. 422-426.
3. Young, SN and Curzon, G. (1972) A method for obtaining linear reciprocal plots with caeruloplasmin and its application in a study of the kinetic parameters of caeruloplasmin substrates. Biochem J, 129, pp. 273-283.
4. Inoue, K., Akaike, T., Miyamoto, Y., Okamoto, T., Sawa, T., Otagiri, M., Suzuki, S., Yoshimura, T. and Maeda, H. (1999) Nitrosothiol formation catalyzed by ceruloplasmin. Implication for cytoprotective mechanism in vivo. J Biol Chem, 274, pp. 27069-27075.
5. Kim, IG and Park, SY. (1998) Requirement of intact human ceruloplasmin for the glutathione-linked peroxidase activity. FEBS Lett, 437, pp. 293-296.
6. Harris, ZL, Takahashi, Y., Miyajima, H., Serizawa, M., MacGillivray, RTA and Gitlin, JD. (1995) Aceruloplasminemia: Molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci USA, 92, pp. 2539-2543.
7. Vassiliev, V., Harris, ZL and Zatta, P. (2005) Ceruloplasmin in neurodegenerative diseases. Brain Res Rev, 49, pp. 633-640.
8. Goldstein, IM, Kaplan, HB, Edelson, HS and Weissmann, G. (1982) Ceruloplasmin: An acute phase reactant that scavenges oxygen-derived free radicals. Ann NY Acad Sci, 389, pp. 368-379.
9. Atanasiu, RL, Stea, D., Mateescu, MA, Vergely, C., Dalloz, F., Briot, F., Maupoil, V., Nadeau, R. and Rochette, L. (1998) Direct evidence of caeruloplasmin antioxidant properties. Mol Cell Biochem, 189, pp. 127-135.
10. Agner, K. (1941) Verdoperoxidase. A ferment isolated from leukocytes. Acta Physiol Scand, pp. 1-62.
11. Blair-Johnson, M., Fiedler, T. and Fenna, R. (2001) Human myeloperoxidase: Structure of a cyanide complex and its interaction with bromide and thiocyanate substrates at 1.9 Å resolution. Biochemistry, 4, pp. 13990-13997.
12. Klebanoff, SJ. (1968) Myeloperoxidase-halide-hydrogen peroxide antibacterial system. J Bacteriol, 95, pp. 2131-2138.
13. Lanza, F. (1998) Clinical manifestation of myeloperoxidase deficiency. J Mol Med, 76, pp. 676-681.
14. Aratani, Y., Koyama, H., Nyui, S., Suzuki, K., Kura, F. and Maeda, N. (1999) Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase. Infect Immun, 67, pp. 1828-1836.
15. Arnhold, J., Osipov, AN, Spalteholz, H., Panasenko, OM and Schiller, J. (2001) Effects of hypochlorous acid on unsaturated phosphatidylcholines. Free Radic Biol Med, 31, pp. 1111-1119.
16. Panasenko, OM, Spalteholz, H., Schiller, J. and Arnhold, J. (2003) Myeloperoxidase-induced formation of chlorohydrins and lysophospholipids from unsaturated phosphatidylcholines. Free Radic Biol Med, 34, pp. 553-562.
17. Schiller, J., Arnhold, J., Grunder, W. and Arnold, K. (1994) The action of hypochlorous acid on polymeric components of cartilage. Biol Chem Hoppe Seyler, 375, pp. 167-172.
18. Aruoma, OI and Halliwell, B. (1987) Action of hypochlorous acid on the antioxidant protective enzymes superoxide dismutase, catalase and glutathione peroxidase. Biochem J, 248, pp. 973-976.
19. Sharonov, BP, Govorova, NJU and Lyzlova, SN. (1988) A comparative study of serum proteins ability to scavenge active oxygen species: O2- and OCl-. Biochem Int, 17, pp. 783-790.
20. Hawkins, CL and Davies, MJ. (2002) Hypochlorite-induced damage to DNA, RNA, and polynucleotides: Formation of chloramines and nitrogen-centered radicals. Chem Res Toxicol, 15, pp. 83-92.
21. Govorova, NIU, Sharonov, BP and Lyzlova, SN. (1989) Erythrocyte oxidative damage by myeloperoxidase. The protective action of serum proteins. Biull Eksp Biol Med, 107, pp. 428-430.
22. Daugherty, A., Dunn, JL, Rateri, DL and Heinecke, JW. (1994) Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest, 94, pp. 437-444.
23. Hazell, LJ, Arnold, L., Flowers, D., Waeg, G., Malle, E. and Stocker, R. (1996) Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J Clin Invest, 97, pp. 1535-1544.
24. Kettle, AJ, Chan, T., Osberg, I., Senthilmohan, R., Chapman, AL, Mocatta, TJ and Wagener, JS. (2004) Myeloperoxidase and protein oxidation in the airways of young children with cystic fibrosis. Am J Respir Crit Care Med, 170, pp. 1317-1323.
25. Carr, AC, Myzak, MC, Stocker, R., McCall, MR and Frei, B. (2000) Myeloperoxidase binds to low-density lipoprotein: Potential implications for atherosclerosis. FEBS Lett, 487, pp. 176-180.
26. Zheng, L., Nukuna, B., Brennan, M-L, Sun, M., Goormastic, M., Settle, M., Schmitt, D., Fu, X., Thomson, L., Fox, PL, Ischiropoulos, H., Smith, JD, Kinter, M. and Hazen, SL. (2004) Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest, 114, pp. 529-541.
27. Govorova, NIU, Sharonov, BP, Iankovskii, OIU and Lyzlova, SN. (1986) Inactivation of active forms of oxygen generated by myeloperoxidase and serum proteins. Dokl Akad Nauk SSSR, 290, pp. 480-483.
28. Yea, CM, Dularay, B. and Elson, CJ. (1991) Identification of a myeloperoxidase inhibitor from normal human serum. Clin Exp Immunol, 84, pp. 347-352.
29. Segelmark, M., Persson, B., Hellmark, T. and Wieslander, J. (1997) Binding and inhibition of myeloperoxidase (MPO): A major function of ceruloplasmin?. Clin Exp Immunol, 108, pp. 167-174.
30. Park, YS, Suzuki, K., Mumby, S., Taniguchi, N. and Gutteridge, JMC. (2000) Antioxidant binding of caeruloplasmin with myeloperoxidase: myeloperoxidase is inhibited, but oxidase, peroxidase and and immunoreactive properties of caeruloplasmin remain intact. Free Radic Res, 33, pp. 261-265.
31. Griffin, SV, Chapman, PT, Lianos, EA and Lockwood, CM. (1999) The inhibition of myeloperoxidase by ceruloplasmin can be reversed by anti-myeloperoxidase antibodies. Kidney Int, 55, pp. 917-925.
32. Sokolov, AV, Pulina, MO, Ageeva, KV, Runova, OL, Zakharova, ET and Vasilyev, VB. (2007) Identification of leukocyte cationic proteins that interact with ceruloplasmin. Biochemistry (Moscow), 72, pp. 872-877.
33. Kokryakov, VN. (1999) Biology of antibiotics of animal origin, Nauka, St. Petersburg
34. Sokolov, AV, Pulina, MO, Ageeva, KV, Ayrapetov, MI, Berlov, MN, Volgin, GN, Markov, AG, Yablonsky, PK, Kolodkin, NI, Zakharova, ET and Vasilyev, VB. (2007) Interaction of ceruloplasmin, lactoferrin and myeloperoxidase. Biochemistry (Moscow), 72, pp. 409-415.
35. Sokolov, AV, Zakharova, ET, Shavlovskii, MM and Vasil'ev, VB. (2005) Isolation of stable human ceruloplasmin and its interaction with salmon protamine. Bioorg Khim, 31, pp. 269-279.
36. Freinstein, G. and Janoff, A. (1975) A rapid method of purification of human granulocyte cationic neutral proteases: Purification and further characterization of human granulocyte elastase. Biochim Biophys Acta, 403, pp. 493-505.
37. Atassi, MZ and Manshouri, T. (1993) Design of peptide enzymes (pepzymes): Surface-simulation synthetic peptides that mimic the chymotrypsin and trypsin active sites exhibit the activity and specificity of the respective enzyme. Proc Natl Acad Sci USA, 90, pp. 8282-8286.
38. Laemmli, UK. (1970) Cleavage of structural proteins during the assembly of the head of Bacteriophag. Nature (London), 227, pp. 680-686.
39. Reszka, KJ, McCormick, ML and Britigan, BE. (2001) Peroxidase- and nitrite-dependent metabolism of the anthracycline anticancer agents daunorubicin and doxorubicin. Biochemistry, 40, pp. 15349-15361.
40. Prozorovski, VN, Rashkovetski, LG, Shavlovski, MM, Vasiliev, VB and Neifakh, SA. (1982) Evidence that human ceruloplasmin molecule consists of homologous parts. Int J Pept Protein Res, 19, pp. 40-53.
41. Panasenko, OM, Chekanov, AV, Vlasova, II, Sokolov, AV, Ageeva, KV, Pulina, MO, Cherkalina, OS and Vasilyev, VB. (2008) A study of the effect of ceruloplasmin and lactoferrin on chlorination activity of leukocytic myeloperoxidase using chemiluminescence method. Biofizika, 53, pp. 573-581.
42. Ehrenwald, E. and Fox, PL. (1994) Isolation of nonlabile human ceruloplasmin by chromatographic removal of a plasma metalloproteinase. Arch Biochem Biophys, 309, pp. 392-395.
43. Sang, QA. (1995) Specific proteolysis of ceruloplasmin by leukocyte elastase. Biochem Mol Biol Int, 37, pp. 573-581.
44. Furtmuller, PG, Zederbauer, M., Jantschko, W., Helm, J., Bogner, M., Jakopitsch, C. and Obinger, C. (2006) Active site structure and catalytic mechanisms of human peroxidases. Arch Biochem Biophys, 445, pp. 199-213.
45. Zaitsev, VN, Zaitseva, I., Papiz, M. and Lindley, PL. (1999) An X-ray crystallographic study of the binding center of azide inhibitor and organic substrates of ceruloplasmin, a multi-copper oxidase in plasma. J Biol Inorg Chem, 4, pp. 579-587.
46. Candeias, LP, Stratford, MR and Wardman, P. (1994) Formation of hydroxyl radicals on reaction of hypochlorous acid with ferrocyanide, a model iron (II) complex. Free Radic Res, 20, pp. 241-249.
47. Gitlin, JD. (1988) Transcriptional regulation of ceruloplasmin gene expression during inflammation. J Biol Chem, 263, pp. 6281-6287.